Header Logo

Gary Chmielewski

Concepts (242)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
20
2020
552
1.640
Why?
Carcinoma, Non-Small-Cell Lung
11
2017
243
0.960
Why?
Thoracotomy
4
2016
30
0.750
Why?
Pneumonectomy
5
2020
77
0.680
Why?
Esophageal Neoplasms
3
2015
50
0.590
Why?
Thoracic Surgery, Video-Assisted
3
2020
22
0.550
Why?
Adenocarcinoma
7
2015
137
0.540
Why?
Unnecessary Procedures
2
2019
27
0.510
Why?
Biomarkers, Tumor
5
2015
205
0.490
Why?
Esophagectomy
2
2011
23
0.460
Why?
Barrett Esophagus
4
2015
16
0.460
Why?
Catheter Ablation
4
2015
70
0.420
Why?
Aged
26
2019
8997
0.370
Why?
Esophageal Diseases
1
2011
4
0.370
Why?
Jejunostomy
1
2011
9
0.370
Why?
Enteral Nutrition
1
2011
66
0.350
Why?
Abnormalities, Drug-Induced
4
2016
7
0.340
Why?
Neoplasm Recurrence, Local
3
2017
206
0.330
Why?
Neoplasm Staging
12
2019
363
0.320
Why?
Male
29
2019
14772
0.320
Why?
Empyema, Pleural
1
2009
1
0.320
Why?
Negative-Pressure Wound Therapy
1
2009
4
0.320
Why?
Intraoperative Complications
1
2009
63
0.310
Why?
Female
30
2019
15212
0.310
Why?
Surgical Wound Infection
1
2009
86
0.290
Why?
Positron-Emission Tomography
3
2011
87
0.290
Why?
Postoperative Complications
4
2016
916
0.290
Why?
Echinocandins
3
2012
6
0.290
Why?
Drainage
2
2009
39
0.280
Why?
Toxicity Tests
4
2016
9
0.270
Why?
Embryonic Development
3
2016
7
0.250
Why?
Middle Aged
20
2017
8923
0.250
Why?
Humans
32
2020
27072
0.250
Why?
Retrospective Studies
11
2017
3538
0.240
Why?
Embryo, Mammalian
2
2016
25
0.230
Why?
Solitary Pulmonary Nodule
2
2015
14
0.220
Why?
Carcinoma, Squamous Cell
2
2019
172
0.220
Why?
Bronchoscopy
3
2019
33
0.210
Why?
Pleurodesis
1
2003
1
0.210
Why?
Pleural Effusion, Malignant
1
2003
4
0.210
Why?
Prognosis
6
2017
785
0.210
Why?
Consensus
2
2020
87
0.200
Why?
Aged, 80 and over
12
2017
4777
0.200
Why?
Treatment Outcome
11
2017
3485
0.190
Why?
Radiosurgery
3
2011
34
0.190
Why?
Antifungal Agents
2
2012
43
0.180
Why?
Survival Analysis
5
2017
257
0.180
Why?
Simulation Training
1
2020
39
0.170
Why?
Education, Medical, Graduate
1
2020
77
0.160
Why?
Cohort Studies
4
2017
1890
0.160
Why?
Computer Simulation
1
2020
195
0.160
Why?
Surgeons
1
2020
87
0.160
Why?
Small Cell Lung Carcinoma
1
2019
7
0.160
Why?
False Positive Reactions
1
2019
34
0.160
Why?
Fetal Development
2
2016
3
0.160
Why?
Registries
4
2015
189
0.150
Why?
Fetus
2
2016
38
0.150
Why?
Neovascularization, Pathologic
2
2015
37
0.150
Why?
Bone and Bones
2
2016
116
0.140
Why?
Risk Assessment
4
2017
624
0.140
Why?
Length of Stay
3
2016
313
0.140
Why?
Clinical Competence
2
2020
206
0.140
Why?
Tracheomalacia
1
2017
4
0.140
Why?
Tracheal Stenosis
1
2017
6
0.140
Why?
Silicones
1
2017
11
0.140
Why?
Airway Obstruction
1
2017
20
0.140
Why?
Multivariate Analysis
5
2017
329
0.140
Why?
Mutagenicity Tests
1
2016
1
0.130
Why?
Teratogens
1
2016
1
0.130
Why?
Hazardous Substances
1
2016
2
0.130
Why?
Pharmaceutical Preparations
1
2016
8
0.130
Why?
Stents
1
2017
82
0.130
Why?
Disease Progression
4
2014
673
0.130
Why?
Insulin-Like Growth Factor I
2
2014
59
0.130
Why?
Models, Animal
1
2016
114
0.130
Why?
Sensitivity and Specificity
2
2009
482
0.130
Why?
Developmental Biology
1
2016
1
0.130
Why?
Ribs
1
2016
15
0.130
Why?
Thoracic Wall
1
2016
12
0.130
Why?
Metformin
1
2016
17
0.130
Why?
Hypoglycemic Agents
1
2016
37
0.130
Why?
Animals
8
2016
3642
0.120
Why?
X-Ray Microtomography
1
2016
80
0.120
Why?
Esophagoscopy
1
2015
15
0.120
Why?
Learning Curve
1
2015
18
0.120
Why?
Rats
5
2016
664
0.120
Why?
Thoracoscopy
2
2019
22
0.120
Why?
Cytokines
2
2014
222
0.120
Why?
Insulin-Like Growth Factor II
1
2014
10
0.120
Why?
Insulin-Like Growth Factor Binding Proteins
1
2014
10
0.120
Why?
Tumor Burden
3
2010
27
0.110
Why?
Diabetes Mellitus, Type 2
1
2016
167
0.110
Why?
Prosthesis Failure
1
2017
523
0.110
Why?
Kaplan-Meier Estimate
2
2015
175
0.110
Why?
Intubation, Intratracheal
2
2016
94
0.110
Why?
Research Design
2
2012
185
0.100
Why?
Interleukin-2 Receptor alpha Subunit
1
2013
11
0.100
Why?
Multiple Pulmonary Nodules
1
2013
11
0.100
Why?
Fundoplication
1
2012
22
0.100
Why?
Predictive Value of Tests
4
2016
474
0.100
Why?
Diagnosis, Differential
2
2015
348
0.100
Why?
Gastroesophageal Reflux
1
2012
27
0.100
Why?
Immunoassay
1
2012
38
0.100
Why?
Nitriles
1
2012
14
0.100
Why?
Tomography, X-Ray Computed
5
2015
683
0.100
Why?
Pyrimidines
1
2012
21
0.100
Why?
Dose-Response Relationship, Drug
4
2016
333
0.100
Why?
Adult
8
2017
7831
0.100
Why?
Triazoles
1
2012
29
0.100
Why?
Disease-Free Survival
3
2017
174
0.100
Why?
Fistula
1
2011
2
0.090
Why?
Gastric Fistula
1
2011
5
0.090
Why?
Chemical and Drug Induced Liver Injury
1
2011
7
0.090
Why?
Nutrition Assessment
1
2011
42
0.090
Why?
Hospitals, Community
1
2011
12
0.090
Why?
Pyrazoles
1
2012
59
0.090
Why?
Behavior, Animal
1
2011
46
0.090
Why?
Community-Institutional Relations
1
2011
15
0.090
Why?
Radiography, Interventional
1
2011
17
0.090
Why?
Algorithms
3
2014
350
0.090
Why?
Prospective Studies
5
2015
1778
0.090
Why?
Medical Oncology
1
2011
44
0.090
Why?
Heart Diseases
1
2011
62
0.090
Why?
Anticarcinogenic Agents
1
2010
18
0.090
Why?
Receptor, IGF Type 1
1
2010
21
0.090
Why?
Risk Factors
5
2015
2302
0.090
Why?
Minority Groups
1
2011
80
0.090
Why?
Bronchi
1
2010
12
0.090
Why?
Age Factors
2
2009
766
0.080
Why?
Clinical Trials as Topic
1
2011
216
0.080
Why?
Patient Selection
1
2011
194
0.080
Why?
Thoracic Surgical Procedures
1
2009
9
0.080
Why?
Antibodies, Monoclonal
1
2010
177
0.080
Why?
Probability
1
2009
88
0.080
Why?
Trachea
1
2010
46
0.080
Why?
Statistics, Nonparametric
1
2009
125
0.080
Why?
Thoracic Surgery
1
2009
26
0.080
Why?
Area Under Curve
3
2014
63
0.080
Why?
Survival Rate
2
2010
342
0.080
Why?
Staphylococcus aureus
1
2009
69
0.080
Why?
Body Mass Index
1
2011
458
0.080
Why?
Recurrence
2
2014
310
0.070
Why?
United States
4
2015
2035
0.070
Why?
Neoplasms
1
2011
237
0.070
Why?
Rats, Inbred F344
3
2012
34
0.070
Why?
Laparoscopy
1
2009
185
0.070
Why?
Staphylococcal Infections
1
2009
162
0.070
Why?
Neoplasm Invasiveness
2
2017
94
0.070
Why?
Rabbits
2
2016
182
0.060
Why?
Time Factors
3
2015
1433
0.060
Why?
Lung
2
2005
168
0.060
Why?
Pregnancy
3
2012
336
0.060
Why?
Pneumonia
2
2019
67
0.060
Why?
Minimally Invasive Surgical Procedures
1
2009
313
0.060
Why?
Protein-Lysine 6-Oxidase
1
2005
2
0.060
Why?
Carcinoma, Bronchogenic
1
2005
6
0.060
Why?
Logistic Models
2
2015
395
0.060
Why?
ROC Curve
2
2014
141
0.050
Why?
Catheters, Indwelling
1
2003
23
0.050
Why?
Follow-Up Studies
3
2014
1792
0.050
Why?
Reproducibility of Results
2
2016
676
0.050
Why?
Proton Pump Inhibitors
2
2012
10
0.050
Why?
Incidence
2
2015
759
0.050
Why?
Brain
1
2011
1649
0.050
Why?
Mediastinoscopy
1
2019
6
0.040
Why?
Sex Factors
2
2012
464
0.040
Why?
Reoperation
2
2015
925
0.040
Why?
Radiography
2
2013
619
0.040
Why?
Early Detection of Cancer
1
2019
102
0.040
Why?
Dilatation
1
2017
10
0.040
Why?
Young Adult
2
2014
1994
0.030
Why?
Drug-Related Side Effects and Adverse Reactions
1
2016
18
0.030
Why?
Pulmonary Diffusing Capacity
1
2016
8
0.030
Why?
Pneumonia, Bacterial
1
2016
11
0.030
Why?
Tracheostomy
1
2016
25
0.030
Why?
Observer Variation
1
2016
96
0.030
Why?
Guidelines as Topic
1
2016
57
0.030
Why?
Chemoradiotherapy, Adjuvant
1
2015
17
0.030
Why?
Protective Factors
1
2015
26
0.030
Why?
Least-Squares Analysis
1
2015
8
0.030
Why?
Databases, Factual
1
2017
347
0.030
Why?
Hospitals, Low-Volume
1
2015
6
0.030
Why?
Hospitals, High-Volume
1
2015
8
0.030
Why?
Chi-Square Distribution
1
2015
139
0.030
Why?
Remission Induction
1
2015
90
0.030
Why?
Cause of Death
1
2015
60
0.030
Why?
Proportional Hazards Models
1
2016
347
0.030
Why?
Diabetes Mellitus
1
2016
127
0.030
Why?
Minnesota
1
2014
6
0.030
Why?
Odds Ratio
1
2015
270
0.030
Why?
Linear Models
1
2015
247
0.030
Why?
Biomarkers
1
2017
562
0.030
Why?
Illinois
1
2014
250
0.030
Why?
Chemokine CCL3
1
2013
8
0.030
Why?
Granuloma
1
2013
13
0.030
Why?
Interleukin 1 Receptor Antagonist Protein
1
2013
14
0.030
Why?
Chemokine CXCL12
1
2013
9
0.030
Why?
Interleukin-10
1
2013
18
0.030
Why?
Respiratory Tract Infections
1
2013
25
0.030
Why?
Interleukin-6
1
2013
74
0.030
Why?
Maternal Exposure
1
2012
1
0.020
Why?
Decision Support Techniques
1
2012
47
0.020
Why?
Voriconazole
1
2012
12
0.020
Why?
Injections, Subcutaneous
1
2012
22
0.020
Why?
Lymphatic Metastasis
1
2012
93
0.020
Why?
Drug Combinations
1
2012
33
0.020
Why?
Tissue Distribution
1
2012
33
0.020
Why?
Drug Evaluation, Preclinical
1
2012
30
0.020
Why?
Animals, Newborn
1
2012
43
0.020
Why?
Cesarean Section
1
2012
30
0.020
Why?
Tumor Necrosis Factor-alpha
1
2013
189
0.020
Why?
Administration, Oral
1
2012
108
0.020
Why?
Hematemesis
1
2011
2
0.020
Why?
Stomach Ulcer
1
2011
4
0.020
Why?
Body Weight
1
2012
134
0.020
Why?
Esophageal Perforation
1
2011
8
0.020
Why?
Fatal Outcome
1
2011
54
0.020
Why?
Gastrointestinal Hemorrhage
1
2011
23
0.020
Why?
Candidiasis
1
2011
24
0.020
Why?
Osteogenesis
1
2012
107
0.020
Why?
Feeding Behavior
1
2012
85
0.020
Why?
Michigan
1
2011
18
0.020
Why?
Sex Distribution
1
2011
78
0.020
Why?
Contrast Media
1
2011
66
0.020
Why?
Radiopharmaceuticals
1
2011
51
0.020
Why?
Maternal-Fetal Exchange
1
2010
6
0.020
Why?
Organogenesis
1
2010
2
0.020
Why?
Program Evaluation
1
2011
120
0.020
Why?
Macaca fascicularis
1
2010
25
0.020
Why?
Immunoglobulins, Intravenous
1
2010
19
0.020
Why?
Healthcare Disparities
1
2011
88
0.020
Why?
Hospitalization
1
2012
300
0.020
Why?
Rupture
1
2010
110
0.020
Why?
Comorbidity
1
2011
481
0.020
Why?
Motor Activity
1
2011
323
0.020
Why?
Mice
1
2012
1395
0.020
Why?
Radiotherapy Dosage
1
2007
99
0.020
Why?
Radiotherapy Planning, Computer-Assisted
1
2007
51
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
137
0.010
Why?
RNA, Messenger
1
2005
310
0.010
Why?
Cognition
1
2011
1339
0.010
Why?
Aging
1
2012
1544
0.010
Why?
Chmielewski's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (242)
Explore
_
Co-Authors (13)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_